(Q42743611)

English

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study

scientific article published on January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

multicenter clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Stefania Tommasi

9

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

object named as

Paola Parrella

8

0 references

Evaristo Maiello

object named as

Evaristo Maiello

15

0 references

Massimiliano Copetti

object named as

Massimiliano Copetti

10

0 references

Nicola Silvestris

14

object named as

Nicola Silvestris

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

author name string

Giuseppe Colucci

1

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Francesco Giuliani

2

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Carlo Garufi

3

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Rodolfo Mattioli

4

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Luigi Manzione

5

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Antonio Russo

6

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Massimo Lopez

7

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Bruno Daniele

11

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Salvatore Pisconti

12

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Guido Tuveri

13

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

415-422

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Systemic therapy for metastatic colorectal cancer: current options, current evidence

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

EGFR antagonists in cancer treatment

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Hepatic resection for metastatic colorectal cancer results in cure for some patients

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000323279

21 January 2018

Identifiers

10.1159/000323279

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42743611&oldid=1968642702"